BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$449M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$254M |
| 3 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$251M |
| 4 |
Meta Platforms (Facebook)
META
|
+$249M |
| 5 |
Microsoft
MSFT
|
+$221M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$266M |
| 2 |
iShares MSCI Brazil ETF
EWZ
|
+$217M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$173M |
| 4 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$159M |
| 5 |
Deere & Co
DE
|
+$132M |
Sector Composition
| 1 | Technology | 14.9% |
| 2 | Financials | 11.27% |
| 3 | Communication Services | 10.04% |
| 4 | Healthcare | 9.47% |
| 5 | Consumer Discretionary | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1851
CSG Systems International
CSGS
$1.86B
| $135K | ﹤0.01% |
3,372
-93
| -3% | -$3.73K |
|
1852
Pegasystems
PEGA
$9.93B
| $135K | ﹤0.01% |
4,304
+1,020
| +31% | +$31.9K |
|
1853
MiMedx Group
MDXG
$1.03B
| $134K | ﹤0.01% |
21,742
+5,302
| +32% | +$32.8K |
|
1854
VEON
VEON
$3.71B
| $134K | ﹤0.01% |
+1,847
| New | +$134K |
|
|
PTLA
1855
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $134K | ﹤0.01% |
5,023
-152,173
| -97% | -$4.05M |
|
|
CSFL
1856
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $134K | ﹤0.01% |
4,762
-2,068
| -30% | -$58K |
|
1857
Enviri
NVRI
$983M
| $133K | ﹤0.01% |
4,670
-923
| -17% | -$26.4K |
|
1858
Albany International
AIN
$1.71B
| $133K | ﹤0.01% |
1,673
-55
| -3% | -$4.37K |
|
|
ONCE
1859
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $133K | ﹤0.01% |
2,431
+189
| +8% | +$10.3K |
|
1860
WD-40
WDFC
$2.86B
| $133K | ﹤0.01% |
770
-74
| -9% | -$12.7K |
|
|
NCI
1861
DELISTED
Navigant Consulting, Inc.
NCI
| $132K | ﹤0.01% |
5,731
+847
| +17% | +$19.5K |
|
1862
Premier
PINC
$2.2B
| $132K | ﹤0.01% |
2,883
+720
| +33% | +$33K |
|
1863
Franklin Electric
FELE
$4.21B
| $132K | ﹤0.01% |
2,790
-6
| -0.2% | -$284 |
|
|
CEQP
1864
DELISTED
Crestwood Equity Partners LP
CEQP
| $132K | ﹤0.01% |
3,583
-5,878
| -62% | -$216K |
|
1865
Amicus Therapeutics
FOLD
$2.46B
| $131K | ﹤0.01% |
10,835
+866
| +9% | +$10.5K |
|
1866
Fabrinet
FN
$12.8B
| $131K | ﹤0.01% |
2,830
| – | – |
|
1867
Telefonica
TEF
$30.3B
| $131K | ﹤0.01% |
20,608
-20,130
| -49% | -$128K |
|
|
MBTF
1868
DELISTED
MBT Financial Corporation
MBTF
| $131K | ﹤0.01% |
11,554
| – | – |
|
1869
Independent Bank
INDB
$3.56B
| $131K | ﹤0.01% |
1,580
-454
| -22% | -$37.5K |
|
1870
FIVE9
FIVN
$2B
| $130K | ﹤0.01% |
2,980
-159,947
| -98% | -$6.99M |
|
|
ARNA
1871
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $130K | ﹤0.01% |
2,822
+235
| +9% | +$10.8K |
|
1872
First Merchants
FRME
$2.31B
| $129K | ﹤0.01% |
2,865
-1,260
| -31% | -$56.7K |
|
|
NXTM
1873
DELISTED
NxStage Medical Inc.
NXTM
| $129K | ﹤0.01% |
4,619
+40
| +0.9% | +$1.12K |
|
1874
Ares Capital
ARCC
$15.7B
| $129K | ﹤0.01% |
7,485
+2,714
| +57% | +$46.7K |
|
|
VRTU
1875
DELISTED
Virtusa Corporation
VRTU
| $129K | ﹤0.01% |
2,395
-113
| -5% | -$6.07K |
|